Share Facebook Twitter LinkedIn Pinterest Email Kymera Therapeutics GAAP EPS of -$0.88 misses by $0.11, revenue of $7.4M misses by $7.41M
Solar stocks crushed as Senate budget bill proposal keeps cuts to solar incentives (ENPH:NASDAQ)June 17, 2025